Figure 1From: Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomasRT-qPCR analysis of 10 variant genes in BRC-responsive and BRC-resistant prolactinomas. Only the differential expression of PRDM2 was statistically significant.Back to article page